Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Antonia Cagnetta"'
Autor:
Pasquale Esposito, Daniela Picciotto, Francesca Costigliolo, Elisa Russo, Lucia Macciò, Giovanna Cenacchi, Antonia Cagnetta, Michele Cea, Roberto M. Lemoli, Francesca Viazzi
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Although rare, C3 glomerulopathy (C3G) is increasingly recognized thanks to the currently available diagnostic skills. C3G is not a single disease but a group of disorders with distinct pathogenesis and progression. Thus, an essential step for its ma
Externí odkaz:
https://doaj.org/article/19f127f16b244722b894407743ebcdfc
Autor:
Elena Maio, Mattia Montanari, Francesco Puglisi, Clara Nurra, Maurizio Miglino, Nicoletta Colombo, Enrico Carminati, Giada Zecchetti, Chiara Vernarecci, Maria Chies, Beatrice Ferro, Massimo Zucchetti, Antonia Cagnetta, Michele Cea, Elisabetta Tedone, Roberto Massimo Lemoli, Fabio Guolo, Paola Minetto
Publikováno v:
HemaSphere, Vol 7, p e7714084 (2023)
Externí odkaz:
https://doaj.org/article/d2230ef64cf445aeb1766d5ad8b3ac2a
Autor:
Carola Riva, Maria Chies, Paola Minetto, Chiara Vernarecci, Elena Maio, Beatrice Ferro, Giada Zecchetti, Maurizio Miglino, Elisabetta Tedone, Nicoletta Colombo, Enrico Carminati, Clara Nurra, Francesco Puglisi, Antonia Cagnetta, Michele Cea, Roberto Massimo Lemoli, Fabio Guolo
Publikováno v:
HemaSphere, Vol 7, p e89713c5 (2023)
Externí odkaz:
https://doaj.org/article/d6ff189978e4428da558a54bc68b6e94
Autor:
Chiara Vernarecci, Beatrice Ferro, Francesco Puglisi, Clara Nurra, Enrico Carminati, Carola Riva, Maria Chies, Elena Maio, Giada Zecchetti, Maurizio Miglino, Nicoletta Colombo, Filippo Ballerini, Antonia Cagnetta, Michele Cea, Elisabetta Tedone, Fabio Guolo, Paola Minetto, Roberto Massimo Lemoli
Publikováno v:
HemaSphere, Vol 7, p e0109137 (2023)
Externí odkaz:
https://doaj.org/article/4b036744cf804c0b8ac89d38b008271b
Autor:
Pamela Becherini, Debora Soncini, Silvia Ravera, Elisa Gelli, Claudia Martinuzzi, Giulia Giorgetti, Antonia Cagnetta, Fabio Guolo, Federico Ivaldi, Maurizio Miglino, Sara Aquino, Katia Todoerti, Antonino Neri, Andrea Benzi, Mario Passalacqua, Alessio Nencioni, Ida Perrotta, Maria Eugenia Gallo Cantafio, Nicola Amodio, Antonio De Flora, Santina Bruzzone, Roberto M. Lemoli, Michele Cea
Publikováno v:
Antioxidants, Vol 12, Iss 2, p 494 (2023)
Cancer cells fuel growth and energy demands by increasing their NAD+ biosynthesis dependency, which therefore represents an exploitable vulnerability for anti-cancer strategies. CD38 is a NAD+-degrading enzyme that has become crucial for anti-MM ther
Externí odkaz:
https://doaj.org/article/0e796c050e73475a981a9b6091ebf662
Autor:
Debora Soncini, Claudia Martinuzzi, Pamela Becherini, Elisa Gelli, Samantha Ruberti, Katia Todoerti, Luca Mastracci, Paola Contini, Antonia Cagnetta, Antonella Laudisi, Fabio Guolo, Paola Minetto, Maurizio Miglino, Sara Aquino, Riccardo Varaldo, Daniele Reverberi, Matteo Formica, Mario Passalacqua, Alessio Nencioni, Antonino Neri, Mehmet K. Samur, Nikhil C. Munshi, Mariateresa Fulciniti, Roberto M. Lemoli, Michele Cea
Publikováno v:
Haematologica, Vol 107, Iss 6 (2021)
Identification of novel vulnerabilities in the context of therapeutic resistance is emerging as a key challenge for cancer treatment. Recent studies have detected pervasive aberrant splicing in cancer cells, supporting its targeting for novel therape
Externí odkaz:
https://doaj.org/article/309434a4c8104d54bfdbb57fcf74b015
Autor:
Debora Soncini, Stefania Orecchioni, Samantha Ruberti, Paola Minetto, Claudia Martinuzzi, Luca Agnelli, Katia Todoerti, Antonia Cagnetta, Maurizio Miglino, Marino Clavio, Paola Contini, Riccardo Varaldo, Micaela Bergamaschi, Fabio Guolo, Mario Passalacqua, Alessio Nencioni, Fiammetta Monacelli, Marco Gobbi, Antonino Neri, Giovanni Abbadessa, Sudharshan Eathiraj, Brian Schwartz, Francesco Bertolini, Roberto M. Lemoli, Michele Cea
Publikováno v:
Haematologica, Vol 105, Iss 10 (2019)
Tyrosine kinases have been implicated in promoting tumorigenesis of several human cancers. Exploiting these vulnerabilities has been shown to be an effective anti-tumor strategy as demonstrated for example by the Bruton's tyrosine kinase (BTK) inhibi
Externí odkaz:
https://doaj.org/article/9164c21af1034b3d9449845503413d8d
Autor:
Antonia Cagnetta, Debora Soncini, Stefania Orecchioni, Giovanna Talarico, Paola Minetto, Fabio Guolo, Veronica Retali, Nicoletta Colombo, Enrico Carminati, Marino Clavio, Maurizio Miglino, Micaela Bergamaschi, Aimable Nahimana, Michel Duchosal, Katia Todoerti, Antonino Neri, Mario Passalacqua, Santina Bruzzone, Alessio Nencioni, Francesco Bertolini, Marco Gobbi, Roberto M. Lemoli, Michele Cea
Publikováno v:
Haematologica, Vol 103, Iss 1 (2018)
Genomic instability plays a pathological role in various malignancies, including acute myeloid leukemia (AML), and thus represents a potential therapeutic target. Recent studies demonstrate that SIRT6, a NAD+-dependent nuclear deacetylase, functions
Externí odkaz:
https://doaj.org/article/47f8604720224f48a3eef275ad4a6f41
Efficacy of nilotinib therapy in patient with CML diagnosed in pre-TKI era and resistant to imatinib
Publikováno v:
Clinical Management Issues, Vol 4, Iss 6S, Pp 23-26 (2015)
Here we report a case of a 32-year-old man, who was diagnosed as having chronic myeloid leukaemia in 1998. After cytoreduction with hydroxyurea, the patient was submitted to high dose chemotherapy with haemopoietic stem cells rescue and reinfusion, a
Externí odkaz:
https://doaj.org/article/d24ba0511381499eb63d76e17c4ab9ed
Autor:
Michele Cea, Debora Soncini, Floriana Fruscione, Lizzia Raffaghello, Anna Garuti, Laura Emionite, Eva Moran, Mirko Magnone, Gabriele Zoppoli, Daniele Reverberi, Irene Caffa, Annalisa Salis, Antonia Cagnetta, Micaela Bergamaschi, Salvatore Casciaro, Ivana Pierri, Gianluca Damonte, Filippo Ansaldi, Marco Gobbi, Vito Pistoia, Alberto Ballestrero, Franco Patrone, Santina Bruzzone, Alessio Nencioni
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e22739 (2011)
Aberrant histone deacetylase (HDAC) activity is frequent in human leukemias. However, while classical, NAD(+)-independent HDACs are an established therapeutic target, the relevance of NAD(+)-dependent HDACs (sirtuins) in leukemia treatment remains un
Externí odkaz:
https://doaj.org/article/062b8d15ac464dd1a91dcf9b866139d6